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Abstract Nck-2 is a newly identified adapter protein compris-
ing three N-terminal SH3 domains and one C-terminal SH2
domain. We have identified in a yeast two-hybrid screen
DOCK180, a signaling protein implicated in the regulation of
membrane ruffling and migration, as a binding protein for Nck-2.
Surface plasmon resonance analyses reveal that the second and
the third SH3 domains interact with the C-terminal region of
DOCK180. The interactions mediated by the individual SH3
domains, however, are much weaker than that of the full length
Nck-2. Furthermore, a point mutation that inactivates the second
or the third SH3 domain dramatically reduced the interaction of
Nck-2 with DOCK180, suggesting that both SH3 domains
contribute to the DOCK180 binding. A major Nck-2 binding site,
which is recognized primarily by the third SH3 domain, has been
mapped to residues 1819^1836 of DOCK180. Two additional,
albeit much weaker, Nck-2 SH3 binding sites are located to
DOCK180 residues 1793^1810 and 1835^1852 respectively.
Consistent with the mutational studies, kinetic analyses by
surface plasmon resonance suggest that two binding events with
equilibrium dissociation constants of 4.15 þ 1.9U1037 M and
3.24 þ 1.9U1039 M mediate the binding of GST-Nck-2 to GST
fusion protein containing the C-terminal region of DOCK180.
These studies identify a novel interaction between Nck-2 and
DOCK180. Furthermore, they provide a detailed analysis of
a protein complex formation mediated by multiple SH3 domains
revealing that tandem SH3 domains significantly enhance
the weak interactions mediated by each individual SH3
domain. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Protein^protein interactions are critical events in signal
transduction controlling cell migration, cytoskeleton organi-
zation, proliferation and di¡erentiation. Many of the protein^
protein interactions are mediated by structurally conserved
protein binding modules such as Src homology-3 (SH3) and
-2 (SH2) domains [1]. SH2 domains bind to phosphorylated
tyrosine residues in speci¢c sequence contexts and therefore
protein^protein interactions mediated by SH2 domains are
regulated by tyrosine phosphorylation. SH3 domains contain
approximately 60 amino acid residues that fold into compact
structures consisting of two small anti-parallel L sheets packed
against each other [1,2]. SH3 domains typically recognize rel-
atively short, proline-rich sequences and interactions mediated
by individual SH3 domains are typically quite weak, with KD
values in the WM range [1^3].
Nck is a family of ubiquitously expressed adapter proteins
comprising primarily three N-terminal SH3 domains and one
C-terminal SH2 domain. The ¢rst member of the Nck family
(Nck-1 or NckK, previously known as Nck) was cloned from
screening of a human melanoma cDNA library [4]. The sec-
ond member of the Nck family, Nck-2 [5] (also known as
NckL [6] or Grb4 [7]) was identi¢ed and cloned recently.
Nck proteins are implicated in cellular signal transduction
regulating cytoskeleton organization, growth and gene expres-
sion [8]. For example, genetic studies have demonstrated that
mutations in the Drosophila Nck homolog dreadlocks
(DOCK) disrupted growth-cone guidance and signaling
[9,10], a process involving formation of ¢lopodial and lamel-
lipodial protrusions and coordination between signal trans-
duction pathways mediated by cell adhesion molecules, small
GTPases of Rho family, and receptor tyrosine kinases. The
importance of the Nck proteins in regulation of fundamental
cellular processes has attracted much attention on the molec-
ular mechanisms whereby they function in signal transduc-
tion. One of the important structural features of Nck proteins
is that they contain multiple SH3 domains in tandem. In this
study, we have utilized yeast two-hybrid screens to identify
proteins that interact with the Nck-2 SH3 domains. Our re-
sults show that DOCK180, a protein that has been implicated
in integrin- and Rac-signaling, membrane ru¥ing and cell
migration [11^13], speci¢cally interacts with the second and
the third SH3 domains of Nck-2. Furthermore, using a com-
bination of mutagenesis and surface plasmon resonance meth-
ods, we have identi¢ed DOCK180 sequences that are recog-
nized by Nck-2 SH3 domains and carried out a kinetic
analysis of the Nck-2^DOCK180 interaction.
2. Materials and methods
2.1. Cells, antibodies and other reagents
Human 293 embryonal kidney cells were from American Type Cul-
ture Collection (Rockville, MD, USA). Human A431 epidermoid car-
cinoma cells were kindly provided by Dr. Je¡rey E. Kudlow (Univer-
sity of Alabama at Birmingham, AL, USA). Media for cell culture
were from Gibco Laboratories (Grand Island, NY, USA) or Medi-
atech/CellgroR (Herndon, VA, USA). Anti-DOCK180 antibody was
from Santa Cruz Biotechnology, Inc. Rabbit polyclonal anti-GST
antibody was from Sigma. Restriction enzymes, DNA modifying en-
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zymes, DNA molecular weight markers and dideoxyribonucleotide
triphosphates (dNTPs) were purchased from Promega. Synthetic oli-
gonucleotides were prepared by Gibco/BRL.
2.2. Yeast two-hybrid assays
A cDNA fragment encoding the third SH3 domain of human Nck-
2 (amino acid residues 176^274) was ampli¢ed by PCR and inserted
into the EcoRI/XhoI site in the pLexA vector (Clontech). The se-
quence of the bait construct (pLexA/SH3) was veri¢ed by DNA se-
quencing and introduced into EGY48[P8OP-lacZ] yeast cells by trans-
formation. The transformants were used to screen a human lung
MATCHMAKER LexA cDNA library (s 5.7U106 independent
clones, Clontech) as previously described [5,14]. Brie£y, the EGY48-
[p8op-lacZ; pLexA/SH3] cells transformed by the library plasmids
were selected by plating on the SD/-His/-Ura/-Trp/-Leu/X-gal medium
(Clontech). The expression of proteins encoded by the pB42AD/libar-
ay vectors was induced by growing the cells in the presence of galac-
tose (SD/Gal/Raf/-His/-Ura/-Trp medium, Clontech). Forty positive
clones, as indicated by activation of both reporter genes (LEU2 and
lacZ), were identi¢ed. pB42AD plasmids were isolated from the pos-
itive yeast clones and used to transform Escherichia coli KC8 cells.
The KC8 cells containing the pB42AD vectors were selected by grow-
ing in medium lacking tryptophan. The pB42AD plasmids were iso-
lated from the KC8 cells and analyzed by restriction digestion. Nine-
teen representative plasmids were selected based on the results from
the restriction digestion analyses. The SH3 binding activity was fur-
ther tested by yeast two-hybrid binding assays using puri¢ed pB42AD
plasmids as described [5,14]. Sequences of the cDNA inserts in the
con¢rmed plasmids were determined by DNA sequencing.
2.3. Site-directed mutagenesis
A QuickChange1 site-directed mutagenesis system (Stratagene) was
used to change the highly conserved tryptophan residues (amino acid
residues 148 and 234) in the second and third SH3 domains of Nck-2
to lysine. The point mutations were con¢rmed by DNA sequencing
using Sequenase Version 2.0 kit (United States Biochemicals).
2.4. DNA sequencing
Sequences of DNA fragments were determined manually using Se-
quenase Version 2.0 kit (United States Biochemicals).
2.5. Expression of recombinant GST fusion proteins containing Nck-2
and DOCK180 sequences
To generate GST fusion proteins, full length or partial human Nck-
2 and DOCK180 cDNA sequences (as speci¢ed in each experiment)
were ampli¢ed by PCR and inserted into the EcoRI/XhoI site of a
pGEX-5x-1 vector (Pharmacia). The recombinant vectors were then
used to transform E. coli M20 cells. The expression of the GST fusion
proteins was induced with IPTG, and the proteins were puri¢ed with
glutathione-Sepharose 4B beads.
2.6. Co-precipitation assays
Human 293 embryonal kidney cells were cultured in Eagle’s MEM
medium supplemented with 10% FBS. Human A431 epidermoid car-
cinoma cells were grown in DMEM medium supplemented with 10%
FBS. Cells were washed once with cold PBS and lysed with the lysis
bu¡er (0.5% Triton X-100 in 50 mM HEPES bu¡er, pH 7.1, contain-
ing 100 mM NaCl, 1 mM EDTA, 1.5 mM MgCl2, 10% glycerol, 10
mM sodium pyrophosphate, 50 mM sodium £uoride, 200 Wm sodium
orthovanadate, 0.2 mM AEBSF, 10 Wg/ml aprotinin, 1 Wg/ml pepsta-
tin A and 5 Wg/ml leupeptin). The lysates were clari¢ed by centrifu-
gation at 10 000Ug for 15 min and pre-incubated with glutathione-
Sepharose 4B beads (Pharmacia) at 4‡C for 0.5 h. The beads were
removed by centrifugation at 3000Ug for 5 min and the clari¢ed cell
lysates were incubated with equal amounts (as speci¢ed in each experi-
ment) of GST fusion proteins containing the wild-type or mutant
forms of Nck-2, or GST alone as a negative control. At the end of
the incubation, the solutions were mixed with glutathione-Sepharose
4B beads, incubated for 1 h or longer, and the GST fusion proteins
were then precipitated with glutathione-Sepharose 4B beads by cen-
trifugation. The precipitates were washed ¢ve times with washing bu¡-
er (0.2% Triton X-100 in 50 mM HEPES bu¡er, pH 7.1, containing
100 mM NaCl, 1 mM EDTA, 1.5 mM MgCl2, 10% glycerol, 10 mM
sodium pyrophosphate, 50 mM sodium £uoride, 200 Wm sodium or-
thovanadate, 0.2 mM AEBSF, 10 Wg/ml aprotinin, 1 Wg/ml pepstatin
A and 5 Wg/ml leupeptin). After washing, DOCK180 that was asso-
ciated with the GST-Nck-2 fusion proteins was detected by immuno-
blotting with a rabbit anti-DOCK180 antibody, a horseradish peroxi-
dase-conjugated anti-rabbit IgG antibody (27 ng/ml) and the
SuperSignalR chemiluminescent substrate (Pierce).
2.7. Analyses of DOCK180^Nck-2 interaction by surface plasmon
resonance
Surface plasmon resonance analyses were performed using a BIA-
core system as previously described [15].
2.7.1. Interactions between Nck-2 and DOCK180 fusion
proteins. 2135 resonance units (RU) of GST fusion protein contain-
ing DOCK180 residues 1754^1865 (2.1 ng/mm2) were covalently
coupled to one £ow cell of a CM5 sensor chip (BIAcore, Inc., Piscat-
away, NJ, USA) using the BIAcore Amine Coupling Kit as described
[16]. The surface was then blocked with ovalbumin (Sigma, St. Louis,
MO, USA) and neutralized with ethanolamine. A second (control)
£ow cell was blocked with ovalbumin and ethanolamine, but was
not exposed to the GST fusion protein containing the C-terminal
region of DOCK180. GST fusion proteins containing the full length
Nck-2 or its SH domains were injected over both £ow cells at a rate of
20 Wl/min for 1.5 min. Dissociation was then monitored for 3 min.
The interaction of the C-terminal region of DOCK180 with Nck-2 (or
Nck-2 SH domains) was disrupted with 5 Wl of 20 mM NaOH be-
tween injections. In some experiments, use of NaOH was avoided by
allowing the proteins to dissociate for 5 h between injections. To test
the integrity of the DOCK180 surface, full length Nck-2 was injected
last. The control (ovalbumin) binding curve was subtracted from the
experimental (DOCK180) binding curve to remove ‘bulk e¡ects’ re-
sulting from refractive index changes due to the presence of the pro-
tein in the bu¡er.
2.7.2. Binding of Nck-2 fusion proteins to DOCK180 peptides. The
following DOCK180 peptides were biotinylated at the N-termini to
facilitate immobilization of the peptides to BIAcore sensor chips:
peptide 1 containing DOCK180 residues 1758^1775 (SPSSPSSQQTP-
PPVTPRA), peptide 2 containing DOCK180 residues 1793^1810
(ADVADVPPPLPLKGSVAD), peptide 3 containing DOCK180 res-
idues 1819^1836 (DLLGSPTPPPPPPHQRHL) and peptide 4 contain-
ing DOCK180 residues 1835^1852 (HLPPPLPSKTPPPPPPKT). Each
biotinylated peptide was injected in HBS bu¡er, pH 7.3, over one of
four £ow cells of a streptavidin-coated BIAcore SA chip. This resulted
in rapid and essentially irreversible binding. GST-Nck-2 wild-type and
its mutants and fragments, or GST alone, were then injected over all
four £ow cells at a rate of 5 Wl/min to determine binding to each
peptide. Resulting sensorgrams were trimmed and scaled for presenta-
tion using BIAcore BIAevaluation software, version 3.0. The experi-
ments were repeated using di¡erent amounts of immobilized peptides
(to avoid the potential mass transfer e¡ects). In experiments (Fig. 4C)
where a smaller amount of the peptides was immobilized, the data
represent the peptide 1 curve (in which binding was negligible) sub-
tracted from the peptide 3 curve. This was required to normalize for
refractive index changes due to di¡erences in bu¡er composition, due
to the smaller signal to noise ratio resulting from the small amount of
ligand immobilized.
2.7.3. Kinetics experiments. GST fusion protein containing the C-
terminal region of DOCK180 was covalently bound to a £ow cell as
described above, except in lower concentration to minimize ‘mass
transport’ e¡ects, i.e. binding limited by the rate of delivery of
GST-Nck-2 to the DOCK180 surface. GST-Nck-2 solutions were in-
jected at 50 Wl/min at concentrations of 0.5, 1.0, 1.5, and 2.0 WM.
Equilibrium and kinetic rate constants were determined using BIA-
evaluation version 2.1 software (BIAcore, Inc., Piscataway, NJ, USA)
and a two-site binding model. KD1 and KD2 (equilibrium constants)
were calculated from kd1/ka1 and kd2/ka2 (ratios of rate constants).
3. Results and discussion
3.1. Identi¢cation of DOCK180 as a Nck-2 binding protein by
yeast two-hybrid screens
To identify proteins that interact with Nck-2 SH3 domains,
we screened a human lung LexA cDNA library (s 5.7U106
independent clones) with a bait construct (pLexA/SH33) en-
coding the third SH3 domain (SH33) of Nck-2 (amino acid
FEBS 24638 26-2-01
Y. Tu et al./FEBS Letters 491 (2001) 193^199194
residues 176^274). Forty positive clones were isolated. Plas-
mids (pB42AD) from the positive clones were puri¢ed and
analyzed by restriction digestion. Nineteen representative
pB42AD plasmids were selected based on restriction digestion
results. Proteins encoded by the puri¢ed pB42AD plasmids
were further tested for their ability to interact with Nck-2
SH33 in yeast two-hybrid binding assays. Inserts from six
plasmids encoding fusion proteins that exhibited strong and
reproducible Nck-2 SH3 binding activity were sequenced. One
cDNA insert was found to encode the C-terminal region (res-
idues 1754^1865) of DOCK180, a protein that has been im-
plicated in integrin- and Rac-signaling [11^13]. In control ex-
periments, elimination of either the DOCK180 sequence or
the Nck-2 SH33 sequence abolished the interaction (Table
1). Furthermore, the ¢rst SH3 domain of Nck-2, unlike the
third SH3 domain, was unable to interact with the DOCK180
fusion protein (Table 1). Taken together, these results suggest
that DOCK180 is a speci¢c binding target of the third SH3
domain of Nck-2.
3.2. Biochemical binding assays con¢rm the interaction of the
full length Nck-2 with DOCK180
To con¢rm the yeast two-hybrid binding results, we tested
the ability of Nck-2 to interact with DOCK180 in a biochem-
ical GST fusion protein pull-down assay. To do this, we in-
cubated mammalian cell lysates with GST-Nck-2, or GST as a
negative control. GST-Nck-2 and GST were precipitated with
glutathione-Sepharose 4B beads. Immunoblotting analyses of
the GST-Nck-2 precipitates showed that DOCK180 was co-
precipitated with GST-Nck-2 (Fig. 1, lane 3). No DOCK180
was detected in the GST precipitate (Fig. 1, lane 2). Thus,
consistent with the yeast two-hybrid results obtained with
the Nck-2 SH33 domain and the DOCK180 C-terminal se-
quence, the full length Nck-2 is capable of interacting with
the full length DOCK180 expressed by mammalian cells.
3.3. Surface plasmon resonance detection of the Nck-2 binding
to the DOCK180 C-terminal region
We next employed surface plasmon resonance, which is a
powerful tool for real time measurement of direct protein^
protein interactions [17^20], to further characterize the inter-
action between Nck-2 and the C-terminal region of
DOCK180. To do this, we covalently coupled a recombinant
GST fusion protein containing the DOCK180 sequence (res-
idues 1754^1865) to a BIAcore sensor chip. GST-Nck-2, or a
GST fusion protein containing Nck-2 SH2 domain (GST-
SH2) as a control, was passed over it by injecting 30 Wl at a
concentration of 1 WM. Nck-2 bound to the recombinant
DOCK180 C-terminal fragment speci¢cally and reversibly
(Fig. 2A, curve a). By marked contrast, GST-SH2 was unable
to interact with the DOCK180 C-terminal fragment (Fig. 2A,
curve b). These results are highly consistent with the data
from the yeast two-hybrid and GST fusion protein pull-
down assays and show that the Nck-2^DOCK180 interaction
can be readily detected by surface plasmon resonance.
3.4. Substitution of the highly conserved tryptophan with a
lysine disrupts the binding of the Nck-2 SH3 domains to
DOCK180
SH3 domains contain a highly conserved tryptophan resi-
due located immediately C-terminal to the n-Src loop. Pre-
vious studies have shown that replacement of this highly con-
served tryptophan with a lysine disrupts protein binding
activities of several SH3 domains (e.g. the SH3 domains of
Abl and Crk) [10,21,22]. To test whether this highly conserved
tryptophan is also required for Nck-2 SH33 to interact with
the C-terminal region of DOCK180, we substituted it with a
lysine residue. The binding of the WCK point SH3 mutant
was ¢rst tested in a yeast two-hybrid binding assay. The re-
sults showed that, unlike the wild-type Nck-2 SH33 domain,
the SH33 WCK point mutant was unable to bind to the
DOCK180 C-terminal fragment (Table 1). To further test
this, we analyzed the DOCK180 binding activities of the
wild-type and mutant forms of Nck-2 SH3 domains by sur-
face plasmon resonance. The third SH3 domain, and to a less
Table 1
Identi¢cation of DOCK180 as a Nck-2 binding protein by yeast
two-hybrid binding assays
pLexA construct pB42AD construct Reporter gene
LEU2 lacZ
pLexA-SH33 pB42AD-DOCK180 + +
pLexA-SH33 pB42AD 3 3
pLexA-lamin C pB42AD-DOCK180 3 3




pLexA-SH33, pLexA-SH33 (W234CK), pLexA-SH31 and pLexA-
lamin C encode LexA fusion proteins containing the third SH3 do-
main of Nck-2 (residues 176^274), the Nck-2 SH33 point mutant in
which the highly conserved tryptophan was substituted with a lysine
residue, the ¢rst SH3 domain of Nck-2 (residues 1^76) and an irrel-
evant protein lamin C respectively. pB42AD-DOCK180 encodes an
AD fusion protein containing the C-terminal region of DOCK180
(residues 1754^1865). Yeast two-hybrid binding assays were per-
formed as described in Section 2.
Fig. 1. Co-precipitation of DOCK180 with GST-Nck-2. A431 cell
lysates (350 Wg) were incubated with 10 Wg of GST-Nck-2 (lane 3)
or 10 Wg of GST as a control (lane 2), for 2 h at 4‡C. GST-Nck-2
and GST were precipitated and associated DOCK180 was detected
by immunoblotting with an anti-DOCK180 antibody as described
in Section 2. Lane 1 was loaded with 14 Wg of A431 cell lysates.
Similar results were obtained with 293 cell lysates (not shown in the
¢gure).
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extent the second SH3 domain, bound to the immobilized
DOCK180 C-terminal fragment (Fig. 2B). However, the
DOCK180 binding activities of the individual SH3 domains
were markedly lower than that of the intact Nck-2 molecule
(Fig. 2A and B). A point mutation at the highly conserved
tryptophan in the second (position 148) or the third (position
234) SH3 domain almost completely abolished the DOCK180
binding mediated by the Nck-2 SH3 domains (Fig. 2B). Con-
sistent with the yeast two-hybrid binding results (Table 1), the
binding of the ¢rst SH3 domain to the DOCK180 C-terminal
fragment was negligible (data not shown). Taken together,
these results demonstrate that (1) the third SH3 domain,
and to a less extent the second SH3 domain, can bind to
the C-terminal region of DOCK180 and (2) the highly con-
served tryptophan is critical for the binding of the Nck-2 SH3
domains to the C-terminal region of DOCK180. Additionally,
the fact that the DOCK180 binding activities of the Nck-2
individual SH3 domains are much weaker than that of the
intact Nck-2 suggests that the interaction of Nck-2 with the
C-terminal region of DOCK180 involves multiple, cooperative
bindings mediated by the two Nck-2 SH3 domains.
3.5. Multiple SH3 domains contribute to the Nck-2^DOCK180
interaction
To assess the contributions from the second and the third
SH3 domains to the Nck-2^DOCK180 interaction, we gener-
ated Nck-2 point mutants in which the critical tryptophan
residue located within the second (residue 148) or the third
(residue 234) SH3 domain is substituted with a lysine. In
addition, we generated a double mutant of Nck-2 in which
the critical tryptophan residues located in the second (residue
148) and the third (residue 234) SH3 domain are substituted
with lysine. GST-Nck-2 fusion proteins containing the single
or the double WCK mutations were puri¢ed (Fig. 3A) and
their DOCK180 binding activity was determined in a pull-
down assay (Fig. 3B). As expected, the GST fusion proteins
containing the wild-type Nck-2 readily interacted with
DOCK180 (Fig. 3B, lane 2). The double mutations that in-
activate both the second and the third SH3 domains almost
completely eliminated the interaction of Nck-2 with
DOCK180 (Fig. 3B, lane 5), con¢rming that the interaction
with DOCK180 is mediated primarily by the second and the
third SH3 domains. Noticeably, a single mutation that elim-
inates either the DOCK180 binding activity of the second SH3
Fig. 2. Real time detection of the interaction between puri¢ed re-
combinant Nck-2 and DOCK180 proteins by surface plasmon reso-
nance. A: Interaction of Nck-2 with DOCK180. Sensorgrams were
obtained by injecting 30 Wl of 1 WM GST-Nck-2 (a) or 1 WM GST-
SH2 (b) over 2135 RU (2.1 ng/mm2) of DOCK180 immobilized
onto a £ow cell of a BIAcore CM5 chip. Arrows indicate beginning
and end of injections. Non-speci¢c binding of the same injections
over immobilized ovalbumin in a control £ow cell of the same chip
has been subtracted from the curves. B: Interactions of Nck-2 SH3
domains with DOCK180. Sensorgrams were obtained by injecting
30 Wl of equal concentration (1 WM) of GST fusion proteins con-
taining the second (SH32) or the third (SH33) SH3 domains of
Nck-2 or their corresponding WCK point mutants (W148K and
W234K) were injected over the same immobilized DOCK180 surface
used in A. Non-speci¢c binding to an ovalbumin surface has been
subtracted.
Fig. 3. Multiple SH3 domains mediate the interaction of Nck-2 with
DOCK180. A: Coomassie Blue staining of GST fusion proteins
containing the wild-type Nck-2 (lane 1) or mutant forms of Nck-2
in which residue W148 (lane 2), W234 (lane 3) or both (lane 4) were
substituted with K. B: DOCK180 binding. Human 293 cell lysates
(300 Wg) were incubated with equal amount (10 Wg) of GST fusion
proteins containing the wild-type Nck-2 (lane 2), the W148CK point
mutant (lane 3), the W234CK point mutant (lane 4) or the double
WCK mutant (lane 5), for 2 h at 4‡C. GST fusion proteins were
precipitated and associated DOCK180 was detected by immunoblot-
ting with an anti-DOCK180 antibody as described in Section 2.
Lane 1 was loaded with 14 Wg of 293 cell lysates.
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domain (Fig. 3B, lane 3) or that of the third SH3 domain
(Fig. 3B, lane 4) also dramatically reduced the interaction of
Nck-2 with DOCK180, suggesting that both the second and
the third SH3 domains contribute to the formation of a stable
complex between Nck-2 and DOCK180.
3.6. DOCK180 sequences recognized by the Nck-2 SH3
domains
We next sought to identify DOCK180 sites that are recog-
nized by the Nck-2 SH3 domains. Inspection of the
DOCK180 protein sequence revealed that the C-terminal re-
gion of DOCK180 contains four potential SH3 recognition
proline-rich sequences. To test experimentally whether these
proline-rich sequences are recognized by Nck-2, we immobi-
lized each of the peptides containing the DOCK180 proline-
rich sequences on BIAcore sensor chips. GST-Nck-2, or GST
as a control, was passed over the sensor chips at a concen-
tration of 1 WM. One of the DOCK180 peptides (peptide 3,
DLLGSPTPPPPPPHQRHL) was readily recognized by GST-
Nck-2 (Fig. 4A, curve a). Two additional DOCK180 sequen-
ces (ADVADVPPPLPLKGSVAD and HLPPPLPSKTPP-
PPPPKT) exhibited much weaker but reproducible Nck-2
binding activity (Fig. 4A, curves b and c). Peptide 1, which
contains DOCK180 sequence SPSSPSSQQTPPPVTPRA,
failed to interact with GST-Nck-2 (Fig. 4A, curve d). In con-
trol experiments, none of the DOCK180 peptides interacted
with GST (data not shown, also see below), con¢rming the
speci¢city of the binding. These results suggest that (1) there
exist multiple Nck-2 binding sites (one major site, two minor
sites) in the C-terminal region of DOCK180 and (2) the
DOCK180 sequence DLLGSPTPPPPPPHQRHL constitutes
the major Nck-2 binding site.
Because both the second and the third SH3 domains of
Nck-2 are utilized in the interaction with DOCK180 (Fig.
3B), we next analyzed the ability of the individual SH3 do-
mains to interact with the major Nck-2 binding site. To do
this, equal concentrations of GST fusion proteins containing
the third SH3 domain or the second SH3 domain, and GST-
Nck-2 as a positive control and GST as a negative control,
were injected into BIAcore sensor chips immobilized with the
peptide 3. As expected, GST-Nck-2 (Fig. 4B, curve a), but not
GST (Fig. 4B, curve d), readily interacted with the DOCK180
Fig. 4. Identi¢cation of DOCK180 sequences recognized by the
Nck-2 SH3 domains. A: Binding of GST-Nck-2 to DOCK180 pep-
tides. Equal amounts of biotinylated DOCK180 peptides, each rep-
resenting one potential SH3 recognition site located in the C-termi-
nal region of DOCK180, were immobilized on a BIAcore SA chip,
each in a di¡erent £ow cell. GST-Nck-2 was injected over all four
peptides at a concentration of 1 WM as described in Section 2.
a = peptide 3 (residues 1819^1836: DLLGSPTPPPPPPHQRHL),
b = peptide 2 (residues 1793^1810: ADVADVPPPLPLKGSVAD),
c = peptide 4 (residues 1835^1852: HLPPPLPSKTPPPPPPKT),
d = peptide 1 (residues 1758^1775: SPSSPSSQQTPPPVTPRA).
B: Binding of individual Nck-2 SH3 domains to peptide 3 of
DOCK180. Equal concentrations (1 WM) of GST fusion proteins
containing Nck-2, (curve a), SH33 (curve b), SH32 (curve c), or
GST (curve d) were injected over sensor chip surfaces immobilized
with peptide 3 of DOCK180. C: Binding of Nck-2 point mutants to
peptide 3 of DOCK180. Equal concentrations (1 WM) of GST fu-
sion proteins containing wild-type Nck-2 (curve a), Nck-2 point mu-
tant (W148K) in which SH32 is inactivated (curve b), Nck-2 point
mutant (W234K) in which SH33 is inactivated (curve c), or Nck-2
double mutant (W148K; W234K) in which both SH32 and SH33
are inactivated (curve d) were injected over sensor chip surfaces im-
mobilized with peptide 3 of DOCK180. Note that the scale in panel
C is di¡erent from panels A and B, due to a smaller amount of im-
mobilized DOCK180 peptide 3 (approximately 8% of that in panels
A and B).
Fig. 5. Kinetics of Nck-2 binding to DOCK180. GST-Nck-2 at con-
centrations of 0.5, 1.0, 1.5, and 2.0 WM was injected at 50 Wl/min
over a surface of immobilized DOCK180 at a density of 2 ng/mm2
to generate these sensorgrams. Each curve was analyzed with BIA-
evaluation version 2.0 software using a multiple binding site model
(Pharmacia). Analysis yielded KD1 = 4.15+1.9U1037 M and KD2 =
3.24+1.9U1039 M.
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peptide. The third SH3 domain (Fig. 4B, curve b), and to a
much less extent the second SH3 domain (Fig. 4B, curve c),
interacted with the DOCK180 peptide. This result suggests
that the DOCK180 sequence is primarily a target of the third
SH3 domain. It is worth noting, however, that the full length
Nck-2 (Fig. 4B, curve a) bound the DOCK180 peptide sig-
ni¢cantly better than the third SH3 domain (Fig. 4B, curve b),
suggesting that the weak binding to the same DOCK180 se-
quence (presumably to a distinct peptide in the close vicinity)
mediated by the second SH3 domain can signi¢cantly enhance
the interaction of Nck-2 with the DOCK180 peptide.
To further assess the contributions of the second and the
third SH3 domains, we analyzed the binding of the full length
Nck-2 WCK mutants, in which either the second SH3 do-
main or the third SH3 domain or both were inactivated, to
the major Nck-2 binding site of DOCK180 (Fig. 4C). Inacti-
vation of the third SH3 domain eliminated most of the bind-
ing activity (Fig. 4C, curves a and c), con¢rming that the
binding is mediated to a large extent by the third SH3 do-
main. Inactivation of the second SH3 domain signi¢cantly
reduced, but did not eliminate, the binding activity (Fig. 4C,
curve b). The remaining binding activity exhibited by the
WCK point mutant in which the second SH3 domain is
inactivated is clearly mediated by the third SH3 domain, as
inactivation of both the second and the third SH3 domains
(Fig. 4C, curve d) almost completely abolished the binding.
These data con¢rm the results obtained with the individual
SH3 domains. Taken together, they indicate that (1) the
DLLGSPTPPPPPPHQRHL site of DOCK180 is preferen-
tially recognized by the third SH3 domain and (2) the binding
mediated by the second SH3 domain, although weak by its
own, signi¢cantly enhances the binding of Nck-2 to the
DLLGSPTPPPPPPHQRHL site. It is interesting to note
that the major Nck-2 SH3 recognition site (DLLGSPTPPPP-
PPHQRHL) is di¡erent from those recognized by other SH3
domains. For example, CRK SH3 domain recognizes two
di¡erent sites (PPPLPLK and PPPLPSK, which are located
within the second and the fourth peptides used in this study)
on DOCK180 [11]. These results clearly show the high degree
of selectivity between di¡erent SH3 domains and suggest that
DOCK180 may function as a sca¡olding protein mediating
formation of multi-protein complexes.
We have also analyzed the interactions of the second
and the third SH3 domains of Nck-2 with DOCK180 peptide
2 (ADVADVPPPLPLKGSVAD) by surface plasmon reso-
nance. Both the second and the third SH3 domains interacted
speci¢cally with peptide 2, although the binding activities were
low (data not shown), which is consistent with the relative
weak binding activity of Nck-2 towards this site (Fig. 4A).
3.7. Kinetics of the Nck-2^DOCK180 interaction
The foregoing mutational experiments show that the inter-
action of Nck-2 with DOCK180 is mediated by multiple sites
from both binding partners, implying that multiple binding
events could occur during the complex formation between
Nck-2 and DOCK180. To test this, we analyzed the kinetics
of the binding of Nck-2 to the C-terminal region of
DOCK180 by surface plasmon resonance, as follows. We im-
mobilized GST fusion protein containing the C-terminal re-
gion of DOCK180 on BIAcore sensor chips and then injected
GST-Nck-2 over the DOCK180 surface at di¡erent concen-
trations (Fig. 5). In control experiments, no binding was de-
tected when GST was passed over the GST-DOCK180 surface
or when GST-Nck-2 was passed over the GST surface (data
not shown), con¢rming the speci¢city of the binding. Kinetic
analyses of the Nck-2^DOCK180 binding data with BIAeval-
uation 2.1 software suggest that two interactions with equilib-
rium dissociation constants (KD1 and KD2) of 4.15 þ
1.9U1037 M and 3.24 þ 1.9U1039 M, respectively, occurred
during the interaction between GST-Nck-2 and GST fusion
protein containing DOCK180 C-terminal fragment (Fig. 5).
Although the a⁄nity measurements are not absolute due to
the presence of GST, the kinetic data are consistent with the
results from the mutational analyses indicating that multiple
sites from each binding partner are involved in the interaction.
Based on the mutational and kinetic analyses, we propose a
model for the complex formation between Nck-2 and
DOCK180. In this model, a strong binding (with Kd in the
nM range) between Nck-2 and DOCK180 is achieved through
two cooperative interactions mediated by two tandem (the
second and the third) SH3 domains, as inactivation of either
SH3 domain signi¢cantly reduced the binding between Nck-2
and DOCK180 (Figs. 3 and 4). One of the two interactions is
mediated by the third SH3 domain of Nck-2 and residues
1819^1836 (DLLGSPTPPPPPPHQRHL) of DOCK180. The
other interaction most likely involves the second SH3 domain
of Nck-2 and either a di¡erent Nck-2 binding site (e.g. resi-
dues 1793^1810, ADVADVPPPLPLKGSVAD) in the same
DOCK180 molecule or residues 1819^1836 of another
DOCK180 molecule that is in the same complex. The relative
weak binding between Nck-2 and DOCK180 occurs when one
of the SH3 domains or some of the Nck-2 binding sites of
DOCK180 are not available (either due to binding to other
proteins or due to mutations as in the mutational studies
described in this paper). It is interesting to compare the inter-
action of Nck-2^DOCK180 with that of Grb2 and SOS, an-
other SH3-mediated interaction. Similar to the interaction be-
tween Nck-2 and DOCK180, the SH3-mediated binding of
Grb2 to SOS is also very tight, with Kd value in the 1039
M range [23]. However, in contrast to the Nck-2^DOCK180
interaction described in this study, the tight SOS binding is
mediated primarily through one (the N-terminal) of the two
SH3 domains of Grb2 [23]. Thus, there are two general mech-
anisms by which a tight protein complex can be formed
through interactions mediated by SH3 domains. The ¢rst
one is through a tight interaction mediated by a single SH3
domain (one example is the formation of the Grb2^SOS com-
plex). The second one is through relatively weak cooperative
interactions mediated by multiple SH3 domains as exempli¢ed
by the Nck-2^DOCK180 interaction shown in this study. Be-
cause the interactions mediated by individual SH3 domains
are typically quite weak (with the notable exception of the
N-terminal SH3 domain of Grb2), the second mechanism is
likely utilized by many proteins containing multiple SH3 do-
mains during assembly of protein complexes. The formation
of a stable protein complex through multiple binding events
mediated by tandem SH3 domains provides cells with a ver-
satile mechanism regulating signal transduction.
In summary, we have identi¢ed a novel interaction between
Nck-2 and DOCK180, a component of the integrin- and Rac-
signaling pathways involved in the regulation of membrane
ru¥ing and cell migration [12,13]. In addition, we have car-
ried out a detailed biochemical analysis of the interaction
between Nck-2 and DOCK180 revealing a general mechanism
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by which two relative weak interactions mediated by tandem
SH3 domains result in the formation of a stable complex.
Nck-2 is concentrated in membrane ru¥es of spreading cells
(Tu and Wu, unpublished observation), where DOCK180 is
known to localize and function [12,13,24]. Recent studies by
Chen et al. have demonstrated that Nck-2 regulates PDGF-
stimulated membrane ru¥ing [25]. Given the well documented
importance of DOCK180 in the regulation of membrane ruf-
£ing and cell migration [12,13,24], the interaction of Nck-2
with DOCK180 described in this paper suggests that the
Nck-2^DOCK180 complex likely plays an important role in
cellular control of cell migration.
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